Medpage Today on MSN8d
Talazoparib-Enzalutamide Improves Survival in Metastatic CRPCAdding talazoparib (Talzenna) to enzalutamide (Xtandi) as initial treatment for metastatic castration-resistant prostate ...
Opens in a new tab or window SAN FRANCISCO -- The addition of radionuclide therapy with 177 Lu-PSMA-617 (Pluvicto) to enzalutamide ... from Novartis and Clarity Pharma; consulting fees for ...
This study was sponsored by Pfizer, Inc. Astellas Pharma Inc. provided enzalutamide. Agarwal had disclosed relationships with Pfizer, Janssen, Bayer, Amgen, and others. Kelly had disclosed ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback